The underlying structure and validity of the RSAT and CPFQ were assessed via factor analysis and correlation with the Apathy Evaluation Scale-Clinician rated version ( AES-C ) in 483 patients who had previously responded to treatment with a selective serotonin reuptake inhibitor .